SALT LAKE CITY, Feb. 8, 2012 /PRNewswire/ -- Ferveo, a global direct seller of science-based nutrition products, revealed more details on the results of clinical trials conducted to test the effectiveness of the first Ferveo product release.
"The first Ferveo product contains a unique and patented proprietary blend of herbs and vitamins not found in any other product in the world," stated founder and CEO Andrew Rinehart. "We're excited to begin seeing the same results of consumption among distributors that we have seen in clinical trials conducted by some of the world's best research departments."
Two of the many ingredients found in the all natural powdered product are Bacopa Monnieri and Rhodiola Rosea. Bacopa Monnieri has been shown in several double blind clinical trials to improve memory capacity (J Atern Complement Med, 2010), decrease stress (Phytother Res, 2007) and help support a healthy immune system (Journal of Alternative and Complementary Enthnopharmocology, 2011). Rhodiola Rosea, when taken in doses of 340-680 mg per day in male and female patients 18-70 years old showed significant decreases in depression (Nord J Psychiatry, 2007). Rhodiola Rosea has additionally been shown to increase mental performance particularly among patients suffering fatigue syndrome (Planta Medica, 2009).
The first Ferveo product additionally contains high doses of Vitamin A, C, D, B6 and B12 along with Zinc, Ginger, Natural Caffeine from the Guarana Seed and Echinacea. The Ferveo product is all natural, contains no sugar and no artificial sweetener or coloring.
Ferveo is meant to be taken each morning and afternoon in order to deliver immediate and long lasting energy, assistance in supporting a healthy immune system and support in increased mental clarity and focus. Athletes have enjoyed the benefits of Ferveo pre-workout as well.
The Ferveo compensation model is a unique binary system payout that pays its distributors up to 45% more than the average binary compensation model. Experts are calling the Ferveo compensation plan "one of the most lucrative in the industry."